Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- NYXH.BR
- Price
- 5.65
- Stock movement up
- +0.01 (0.18%)
- Company name
- Nyxoah
- Exchange
- (BR ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Instruments & Supplies
- Market cap
- 211.46M
- Ent value
- 211.83M
- Price/Sales
- 44.13
- Price/Book
- 1.76
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 28.24%
- 1 year return
- -37.50%
- 3 year return
- -27.97%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-12
DIVIDENDS
NYXH.BR does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 44.13 |
| Price to Book | 1.76 |
| EV to Sales | 44.20 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 37.43M |
| EPS (TTM) | -1.27 |
| FCF per share (TTM) | -1.23 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 4.79M |
| Gross profit (TTM) | 2.99M |
| Operating income (TTM) | -47.34M |
| Net income (TTM) | -43.53M |
| EPS (TTM) | -1.27 |
| EPS (1y forward) | -1.50 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 62.48% |
| Operating margin (TTM) | -987.96% |
| Profit margin (TTM) | -908.49% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 27.72M |
| Net receivables | 2.61M |
| Total current assets | 89.67M |
| Goodwill | 0.00 |
| Intangible assets | 49.31M |
| Property, plant and equipment | 7.78M |
| Total assets | 148.23M |
| Accounts payable | 4.12M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 16.38M |
| Total liabilities | 28.09M |
| Shareholder's equity | 120.14M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -34.58M |
| Capital expenditures (TTM) | 7.71M |
| Free cash flow (TTM) | -42.28M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -36.24% |
| Return on Assets | -29.37% |
| Return on Invested Capital | -33.82% |
| Cash Return on Invested Capital | -32.84% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 5.75 |
| Daily high | 5.88 |
| Daily low | 5.55 |
| Daily Volume | 98K |
| All-time high | 29.90 |
| 1y analyst estimate | 13.90 |
| Beta | 0.55 |
| EPS (TTM) | -1.27 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 13 May 2025 |
Downside potential
Loading...
Downside potential data
| NYXH.BR | S&P500 | |
| Current price drop from All-time high | -81.10% | -12.89% |
| Highest price drop | -87.26% | -56.47% |
| Date of highest drop | 18 Jan 2024 | 9 Mar 2009 |
| Avg drop from high | -55.30% | -11.07% |
| Avg time to new high | 78 days | 12 days |
| Max time to new high | 964 days | 1805 days |
COMPANY DETAILS
Marketcap
211.46M
Marketcap category
Small-cap
Description
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Employees
146
Website
Investor relations
-
SEC filings
CEO
Country
Belgium
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found